The OHSU Knight Cancer Institute is a world leader in treating leukemia. Our director, Dr. Brian Druker, is an internationally recognized pioneer in precision cancer medicine. Dr. Druker played a central role in developing Gleevec, a daily pill for chronic myelogenous leukemia (CML) that has saved tens of thousands of lives. Now he is helping lead Beat AML, a major effort to find better treatments for acute myeloid leukemia.
Every Knight Cancer employee is expected to embody our guiding principles:
One senior research assistant position is available for a motivated candidate to join the Zhang laboratory in the Division of Oncological Science within the Knight Cancer Institute at Oregon Health & Science University (OHSU). The Division of Oncological Science is a collaborative and multidisciplinary division with a broad range of expertise and well established research programs in the following four disciplines: cancer system biology, medicinal medicine, cancer data science, and cancer population science.
This position will assist in research that shows how temporal, spatial, and dose perturbation of oncogenes and tumor suppressor genes predispose to leukemia development and how could we use the leukemia specific vulnerabilities, including the haploinsufficient phenotype observed in patients with chromosome and copy number deletions to develop synthesize lethal therapeutics. Please check Zhang lab’s webpage (https://www.ohsu.edu/school-of-medicine/zhang-lab/research) for detailed information.
Duties include:
Education & experience:
Knowledge, skills, and abilities:
Apply online. Please be sure to upload a Cover Letter and Resume/CV.
We offer a variety of benefits on top of joining a thriving organization:
#linkedin #indeed #knightcancerjobs #knightresearchandlabjobs #knightresearchjobs
Software Powered by iCIMS
www.icims.com